ICMR ANd NIF

ICMR and NIF sign MoU

National Innovation Foundation has been scouting grassroots innovations and traditional knowledge (TK) from different parts of the country with the help of Honeybee network and other collaborators for the past six years. Out of about 50,000 innovations and tk practices from over 400 districts, about 30,000 practices deal with herbal remedies for human and animal ailments. It is obvious that we have to screen all the unique practices that are not mentioned in classical Ayurveda or Siddha or Yunani literature, etc., and add value to them so that we can share the benefits with the knowledge providers. If we do not do it, there will be no case for pursuing the scouting any more. Why should people share their knowledge with us, if they are not going to benefit from it? Not only then such a precious knowledge base will be eroded but society will also be deprived of many useful herbal drugs, which could provide relief from many ailments that might not be treated so well otherwise. The awareness about the therapeutic value of a potent species and the hazardous effect of any species also needs to be spread among the users. There is also the added danger that organized industry may exploit such knowledge, and the knowledge holders may not get a fair share of the benefits.

To address these issues, National Innovation Foundation (NIF) signed a Memorandum of Understanding (MoU) on 23.06.2006 with Indian Council of Medical Research (ICMR). Prof. N K Ganguly, Director General, ICMR and Prof. Anil K Gupta, Executive Vice Chairperson, NIF India signed the MoU at ICMR Headquarters at New Delhi be valid for a period of five years. This is a pioneering collaboration in the field of medical science. Never before, such a synergy was achieved between informal, uncodified and non-classical health related people’s knowledge and the apex institution for medical research in the country. The collaboration will focus on drug development from grassroots traditional knowledge-based practices that incorporate either use of new
medicinal plants not reported in any Indian codified literature or new use
of already mentioned medicinal plants or in the case of multi-herb formulations, one of the ingredients should satisfy either of the above two conditions. This will also serve to recognize, respect and reward the knowledge rich, economically poor indigenous people, as is ethically required for any clinical trial with herbal medicines based on folklore knowledge.
  While the practices will be documented and sourced from the rich NIF database,
ICMR will work towards validating the safety and efficacy of the practices that are claimed to have therapeutic value by grassroots healers. A monitoring committee comprising representatives of both organizations and several eminent scientists of the country will monitor the progress. Any benefit generated will largely go to the traditional knowledge holders and partly to other stakeholders in the value chain to the extent of their involvement. 



It is hoped that this collaboration will be scaled up several fold during the eleventh
Five-Year plan.

List of Participants at the MoU signing ceremony: 

Prof. N. K. Ganguly, DG, ICMR 



Prof. Anil K. Gupta, EVC, NIF 



Prof. S.D. Seth, Chair in C.P., ICMR 



Dr. O.P. Agarwal, EMS (CSIR), ICMR 



Dr. V. Muthuswamy, Sr DDG (BMS), ICMR 



Dr. K. Satyanarayana, Sr DDG (P&I), ICMR 



Dr. S. D. Kholkute, OIC, RMRC, Belgaum 



Dr. Nandini K. Kumar, DDG (BMS), ICMR 



Dr. Sanjeeva Kumar Majumdar, Fellow, NIF